Gabather AB (publ) (GABA.ST)

SEK 0.04

(-10.26%)

Gross Profit Summary of Gabather AB (publ)

  • Gabather AB (publ)'s latest annual gross profit in 2023 was - SEK , down 0.0% from previous year.
  • Gabather AB (publ)'s latest quarterly gross profit in 2024 Q2 was - SEK , down 0.0% from previous quarter.
  • Gabather AB (publ) reported a annual gross profit of - SEK in annual gross profit 2022, down 0.0% from previous year.
  • Gabather AB (publ) reported a annual gross profit of - SEK in annual gross profit 2021, down 0.0% from previous year.
  • Gabather AB (publ) reported a quarterly gross profit of - SEK for 2024 Q2, down 0.0% from previous quarter.
  • Gabather AB (publ) reported a quarterly gross profit of - SEK for 2023 Q3, down 0.0% from previous quarter.

Annual Gross Profit Chart of Gabather AB (publ) (2023 - 2014)

Historical Annual Gross Profit of Gabather AB (publ) (2023 - 2014)

Year Gross Profit Gross Profit Growth
2023 - SEK 0.0%
2022 - SEK 0.0%
2021 - SEK 0.0%
2020 - SEK 100.0%
2019 -84.18 Thousand SEK 0.0%
2018 -84.18 Thousand SEK -28.85%
2017 -65.33 Thousand SEK -10.64%
2016 -59.05 Thousand SEK -1182.9%
2015 -4603.00 SEK 93.57%
2014 -71.63 Thousand SEK 0.0%

Peer Gross Profit Comparison of Gabather AB (publ)

Name Gross Profit Gross Profit Difference
AcuCort AB 6.59 Million SEK 100.0%
AlzeCure Pharma AB (publ) -476 Thousand SEK 100.0%
BioGaia AB (publ) 950.19 Million SEK 100.0%
Enzymatica AB (publ) 31.86 Million SEK 100.0%
Enorama Pharma AB (publ) -3.9 Million SEK 100.0%
Klaria Pharma Holding AB (publ.) -9000.00 SEK 100.0%
Moberg Pharma AB (publ) -2.09 Million SEK 100.0%
Nanexa AB (publ) 59.15 Million SEK 100.0%
Newbury Pharmaceuticals AB (publ) 16.03 Million SEK 100.0%
ODI Pharma AB -1.34 Million SEK 100.0%
Orexo AB (publ) 549.9 Million SEK 100.0%
Probi AB (publ) 220.21 Million SEK 100.0%
Swedencare AB (publ) 164.8 Million SEK 100.0%
Swedish Orphan Biovitrum AB (publ) 14.05 Billion SEK 100.0%
Toleranzia AB -919 Thousand SEK 100.0%
Vivesto AB -10.65 Million SEK 100.0%